Digital transformation in pharma and med devices

In today’s volatile, uncertain, complex, and ambiguous (VUCA) environment, the digital transformation of supply chains in the pharma and medical technology sectors is no longer optional—it is foundational. Promoting these thoughts, Anil Suri, VP- APAC and Head of Supply Chain Management, Sahajanand Medical Technologies delivered a talk on the need of digital transformation in pharma and med devices. 

Suri emphasised that technology is a great enabler. However, successful and meaningful supply chain transformations in the pharma and med devices sectors are driven by the mindset of the leaders and the culture of an organisation. 

True change requires more than implementing digital tools—it demands a commitment to breaking down silos both within organisations and across the broader supply ecosystem

True change requires more than implementing digital tools—it demands a commitment to breaking down silos both within organisations and across the broader supply ecosystem. Collaboration with supply partners, grounded in transparency and shared goals, is essential to unlocking the full value of digitalisation. 

The ability to respond to disruption, meet regulatory demands, and serve patients effectively hinges on building agile, resilient, and intelligent supply networks.

Transitioning from reactive to predictive supply chain models delivers tangible returns on investment. These include enhanced forecast accuracy, optimised inventory levels, and significant cost efficiencies. By harnessing data, advanced analytics, and real-time visibility, pharma and medtech companies can build future-ready supply chains that not only respond to change but anticipate it.